Patents/Inventors

Mark W. Leonard

Burlingame, CAUS3 patents

3 Patents

US124471782025
Method of Treatment Using Anti-cd19 Rituximab-resistant Chimeric Antigen Receptors
Allogene Therapeutics, Inc.
0 cites
US122953622025
Formulations and Processes for CAR T Cell Drug Products
Allogene Therapeutics, Inc.
0 cites
US118966172024
Polynucleotides Encoding Rituximab-resistant Chimeric Antigen Receptors
ALLOGENE THERAPEUTICS, Inc.
0 cites